Canaan Lifescience Pharmaceuticals Limited

Canaan Lifescience Pharmaceuticals Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2017PLC325227 Incorporated 23 October 2017 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma MSME · Micro
Revenue · FY 2025
₹84.23 Lakh
▲ 20% YoY
Net profit · FY 2025
₹2.2 Lakh
Net margin 2.6%
EBITDA · FY 2025
₹2.49 Lakh
EBITDA margin 3%
Authorised capital
₹3 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Canaan Lifescience Pharmaceuticals Limited

Data last updated:

Canaan Lifescience Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 October 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PLC325227. Its GSTIN is 07AAQCA1605G1ZV (Delhi).

The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Avon Forever Industries Limited. It is led by directors including Yogesh Rohidas Lanke and Nagnath Shktishiv Satpute.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Rz 201/17 Tughlakabad Extension, New Delhi, Delhi, India – 110019.

As per the financials filed for FY 2025, the company reported a revenue of ₹84.23 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹2.2 Lakh (net margin 2.6%) and EBITDA of ₹2.49 Lakh (EBITDA margin 3%).

Canaan Lifescience Pharmaceuticals Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0283333). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999DL2017PLC325227
Registration Number 325227
Incorporation Date 23 October 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0283333

Recognitions & Rankings of Canaan Lifescience Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-26-0283333

Contact details

Canaan Lifescience Pharmaceuticals Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Rz 201/17 Tughlakabad Extension, New Delhi, Delhi, India – 110019
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Canaan Lifescience Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Canaan Lifescience Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Canaan Lifescience Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Canaan Lifescience Pharmaceuticals Limited, buy the company report.

Financials of Canaan Lifescience Pharmaceuticals Limited

FY 2024 filings available

Canaan Lifescience Pharmaceuticals Limited reported revenue of ₹84.23 Lakh (up 20% YoY) for FY 2025.

Revenue · FY 2025
₹84.23 Lakh ▲ 20%
Net profit · FY 2025
₹2.2 Lakh margin 2.6%
EBITDA · FY 2025
₹2.49 Lakh margin 3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 20%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 30%
5 years · compounded
▲ 16%

Revenue rose 20% in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.49 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.2 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3%
Net Profit Margin2.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Canaan Lifescience Pharmaceuticals Limited, buy the company report.

Board of directors of Canaan Lifescience Pharmaceuticals Limited

Canaan Lifescience Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Yogesh Rohidas LankeDirector26 Feb 20215 Years 8 MonthsCurrent
Nagnath Shktishiv SatputeDirector26 Feb 20215 Years 8 MonthsCurrent
Abhinav Maheshwari SohanlalDirector23 Oct 20179 Years 0 MonthsCurrent

Peer comparison

Canaan Lifescience Pharmaceuticals Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kruger Nutra Med Private Limited₹84.38 Lakh (FY 2025)2.0%New Delhi, Delhi, India
Sigma Solvents and Pharmaceuticals Limited₹84.35 Lakh (FY 2025)-29.0%Mehsana, Gujarat, India
Italia Pharmaceuticals Private Limited₹84.26 Lakh (FY 2024)102.0%Indore, Madhya Pradesh, India
Canaan Lifescience Pharmaceuticals Limitedthis company₹84.23 Lakh (FY 2025)₹2.2 Lakh2.6%20.0%New Delhi, Delhi, India
Vivaceutical Private Limited₹83.85 Lakh (FY 2024)21.0%Mohali, Punjab, India

To see the full peer comparison of Canaan Lifescience Pharmaceuticals Limited, buy the company report.

Auditor

Canaan Lifescience Pharmaceuticals Limited is audited by SHARMA KUMAR & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
SHARMA KUMAR & ASSOCIATESFY 2023030842N

Shareholding

The shareholding of Canaan Lifescience Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Canaan Lifescience Pharmaceuticals Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Canaan Lifescience Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Canaan Lifescience Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAQCA1605G1ZVDelhiActive04 Jul 2018

To see the full GST registrations and return filing status of Canaan Lifescience Pharmaceuticals Limited, buy the company report.

Recent activity

Canaan Lifescience Pharmaceuticals Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Prasad Bhosale Ashok ceased to be Director on 27 Feb 2021.

AGM
Canaan Lifescience Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Canaan Lifescience Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Prasad Bhosale Ashok ceased to be Director.
Ceased
Vishakha Prakash Desale ceased to be Director.
Appointed
Nagnath Shktishiv Satpute was appointed as Director.
Appointed
Yogesh Rohidas Lanke was appointed as Director.
Ceased
Gitika Maheshwari Abhinav ceased to be Director.
Ceased
Rajvinder Singh ceased to be Director.
Ceased
Sunil Bhardwaj ceased to be Director.
Appointed
Abhinav Maheshwari Sohanlal was appointed as Director.
Incorporation
23 Oct 2017
Canaan Lifescience Pharmaceuticals Limited was registered on 23 Oct 2017 with Roc Delhi & aged 9 years 28 days as per MCA records.

Frequently asked questions

Canaan Lifescience Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 October 2017 (9+ years old) and is registered under CIN U74999DL2017PLC325227.

Canaan Lifescience Pharmaceuticals has 3 current directors:

The latest financial statements of Canaan Lifescience Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Canaan Lifescience Pharmaceuticals is 07AAQCA1605G1ZV, registered in Delhi.

The CIN (Corporate Identification Number) of Canaan Lifescience Pharmaceuticals is U74999DL2017PLC325227. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Canaan Lifescience Pharmaceuticals was incorporated on 23 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Canaan Lifescience Pharmaceuticals by revenue are Kruger Nutra Med Private Limited, Sigma Solvents and Pharmaceuticals Limited, Italia Pharmaceuticals Private Limited, Vivaceutical Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Prasad Bhosale Ashok ceased to be Director on 27 Feb 2021. Vishakha Prakash Desale ceased to be Director on 27 Feb 2021. Nagnath Shktishiv Satpute was appointed as Director on 26 Feb 2021. Canaan Lifescience Pharmaceuticals has 8 board changes on record in total.

Yes, Canaan Lifescience Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0283333).

The registered office of Canaan Lifescience Pharmaceuticals is at Rz 20117 Tughlakabad Extension, New Delhi, Delhi, India – 110019.

Canaan Lifescience Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.